Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-01 | New | $3,402,704 | $3,402,704 | Equity Only | 06b | SEC link |
| 2025-02-05 | New | $3,333,333 | $3,333,333 | Equity and Debt | 06b | SEC link |
| Name | Role |
|---|---|
| Masatoshi Hagiwara | Director |
| Takashi Kiyoizumi | Director, Executive |
| David Snyder | Director |
| Nobuhiro Yagi | Director |